Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched study. - Su Y; Liang Y; Zhong D; Chen Y; Ma S; Wang M; Yang Q; Yan H; Huang X (Frontiers in immunology, 2026)